Kaplan Medical Center is a hospital in Rehovot, Israel, located in the south of the city next to Bilu Junction. It is owned and operated by Clalit Health Services.

During the past decade, Kaplan Medical Center conducted 140 clinical trials. In the 10-year time frame, 140 clinical trials started and 75 clinical trials were completed, i.e. on average, 53.6% percent of trials that started reached the finish line to date. In the past 5 years, 52 clinical trials started and 51 clinical trials were completed. i.e. 98.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaplan Medical Center" #1 sponsor was "Hoffmann-La Roche" with 15 trials, followed by "Kaplan Medical Center" with 13 trials sponsored, "Celgene" with 10 trials sponsored, "Eli Lilly and Company" with 10 trials sponsored and "Bayer" with 10 trials sponsored. Other sponsors include 163 different institutions and companies that sponsored additional 119 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaplan Medical Center" #1 collaborator was "Hoffmann-La Roche" with 3 trials as a collaborator, "Regeneron Pharmaceuticals" with 3 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator and "Canadian Cancer Trials Group" with 2 trials as a collaborator. Other collaborators include 79 different institutions and companies that were collaborators in the rest 78 trials.

According to Clinical.Site data, the most researched conditions in "Kaplan Medical Center" are "Ulcerative Colitis" (15 trials), "Crohn's Disease" (10 trials), "Breast Cancer" (9 trials), "Crohn Disease" (7 trials) and "Heart Failure" (7 trials). Many other conditions were trialed in "Kaplan Medical Center" in a lesser frequency.

Most popular intervention types in "Kaplan Medical Center" are "Drug" (167 trials), "Other" (26 trials), "Device" (21 trials), "Biological" (14 trials) and "Procedure" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (66 trials), "placebo" (6 trials), "Cyclophosphamide" (5 trials), "Lenalidomide" (5 trials) and "Paclitaxel" (5 trials). Other intervention names were less common.

The vast majority of trials in "Kaplan Medical Center" are 202 trials for "All" genders, 20 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Kaplan Medical Center". undefined are not yet recruiting, 29 are recruiting, 30 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 112 completed trials in Kaplan Medical Center, undefined suspended trials, and 30 terminated clinical trials to date.

Out of the total trials that were conducted in Kaplan Medical Center, 9 "Phase 1" clinical trials were conducted, 48 "Phase 2" clinical trials and 126 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 23 trials that are defined as “Not Applicable".

Kaplan Medical Center has several departments that took part in Clinical trials: "Kaplan Medical Center; Oncology Inst." - 11 trials, "Kaplan Medical Center; Ophtalmology" - 8 trials, "Heart Institute, Kaplan Medical Center" - 2 trials